Brand

Ardelyx

Ardelyx—Ardelyx™ seeks to develop therapeutics that act exclusively in the gastrointestinal tract and that are devoid of systemic exposure. Its drug candidates target important diseases, as well as pathologies with a specific inflammatory pathway. Its technology relies on non-absorbable small molecules with highly specific modes of action. www.ardelyx.com